SEC Form 4 · accession 0001493152-18-009768

ONCOSEC MEDICAL Inc · ONCS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Financial Officer

Period of report

Jun 15, 2018

Accepted (ET)

Jul 6, 2018 · 4:40 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001444307

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Jun 15, 2018	M	100,000	—	A	255,000	D
Common Stock^F1	Jun 15, 2018	M	100,000	—	A	355,000	D
Common Stock^F2	Jun 18, 2018	S	12,613	$1.386	D	342,387	D
Common Stock^F2	Jun 19, 2018	S	4,171	$1.364	D	338,216	D
Common Stock^F2	Jun 20, 2018	S	24,906	$1.422	D	313,310	D
Common Stock^F2	Jun 21, 2018	S	4,944	$1.401	D	308,366	D
Common Stock^F2	Jun 22, 2018	S	6,710	$1.418	D	301,656	D
Common Stock^F2	Jun 25, 2018	S	458	$1.405	D	301,198	D
Common Stock^F2	Jun 26, 2018	S	10,673	$1.398	D	290,525	D
Common Stock^F2	Jun 27, 2018	S	7,832	$1.374	D	282,693	D
Common Stock^F2	Jun 28, 2018	S	3,532	$1.401	D	279,161	D
Common Stock^F2	Jun 29, 2018	S	2,420	$1.38	D	276,741	D
Common Stock^F2	Jul 5, 2018	S	6,725	$1.312	D	270,016	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Units^F1	—	Jun 15, 2018	M	100,000	D	Mar 4, 2019	Mar 4, 2019	Common Stock	100,000	0	D
Restricted Stock Units^F1	—	Jun 15, 2018	M	100,000	D	Mar 29, 2020	Mar 29, 2020	Common Stock	100,000	0	D

F1Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
F2Sale to cover taxes on restricted stock unit vesting.